The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

Mostrar outras versões (1)

Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R
Formato:	Journal article
Idioma:	English
Publicado em:	BioMed Central 2007
Assuntos:	Malaria Tropical medicine Infectious diseases

Registros relacionados

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
por: Amin, A, et al.
Publicado em: (2007)

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
por: Otieno Dorothy N, et al.
Publicado em: (2007-05-01)

The decline in paediatric malaria admissions on the coast of Kenya
por: Okiro, E, et al.
Publicado em: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
por: Zurovac, D, et al.
Publicado em: (2007)

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
por: Wasunna, B, et al.
Publicado em: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
por: Sipilanyambe, N, et al.
Publicado em: (2008)

Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector
por: Amin, A, et al.
Publicado em: (2005)

Malaria early warning in Kenya
por: Hay, S, et al.
Publicado em: (2001)

Evidence for over-dispersion in the distribution of clinical malaria episodes in children
por: Mwangi, T, et al.
Publicado em: (2008)

Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya
por: Noor, A, et al.
Publicado em: (2003)

Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project
por: Guerra, C, et al.
Publicado em: (2007)

Distribution of the main malaria vectors in Kenya
por: Okara, R, et al.
Publicado em: (2010)

The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya
por: Atkinson, S, et al.
Publicado em: (2007)

The risks of malaria infection in Kenya in 2009
por: Noor, A, et al.
Publicado em: (2009)

Molecular pathological investigation of the pathophysiology of fatal malaria
por: Prapansilp, P
Publicado em: (2012)

Access and barriers to measures targeted to prevent malaria in pregnancy in rural Kenya
por: Gikandi, P, et al.
Publicado em: (2008)

Artemisinin antimalarials: preserving the "magic bullet"
por: Maude, R, et al.
Publicado em: (2010)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
por: Zurovac, D, et al.
Publicado em: (2008)

The Activity of Mixed Microalgae Polysaccharides from Indonesia as Anti-Malaria in Vitro
por: Mahendra Pujiyanto, et al.
Publicado em: (2022-08-01)

The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya
por: Omumbo, J, et al.
Publicado em: (2004)

Standardizing estimates of the Plasmodium falciparum parasite rate
por: Smith, D, et al.
Publicado em: (2007)

Morbidity and mortality due to Plasmodium vivax malaria in Papua, Indonesia and its control using antimalarial drugs
por: Douglas, N
Publicado em: (2011)

The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren
por: Brooker, S, et al.
Publicado em: (2006)

Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children
por: Noor, A, et al.
Publicado em: (2007)

Plasmodium infection and its risk factors in eastern Uganda
por: Pullan, R, et al.
Publicado em: (2010)

Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
por: Kloprogge, F
Publicado em: (2013)

Ranking of elimination feasibility between malaria-endemic countries
por: Tatem, A, et al.
Publicado em: (2010)

Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
por: Njogu, J, et al.
Publicado em: (2008)

Barriers to prompt and effective malaria treatment among the poorest population in Kenya
por: Chuma, J, et al.
Publicado em: (2010)

The uncertain burden of Plasmodium falciparum epidemics in Africa
por: Cox, J, et al.
Publicado em: (2007)

Malaria in Africa: progress and prospects in the decade since the Abuja Declaration
por: Snow, R, et al.
Publicado em: (2010)

An immune basis for malaria protection by the sickle cell trait
por: Williams, T, et al.
Publicado em: (2005)

Information for decision making from imperfect national data: tracking major changes in health care use in Kenya using geostatistics
por: Gething, P, et al.
Publicado em: (2007)

Revisiting the basic reproductive number for malaria and its implications for malaria control
por: Smith, D, et al.
Publicado em: (2007)

Wealth, mother's education and physical access as determinants of retail sector net use in rural Kenya
por: Noor, A, et al.
Publicado em: (2006)

Mapping the global extent of malaria in 2005
por: Guerra, C, et al.
Publicado em: (2006)

Strategies for improving radical cure in P. vivax malaria
por: John, G
Publicado em: (2012)

The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
por: Zurovac, D, et al.
Publicado em: (2006)

Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
por: Pongtavornpinyo, W, et al.
Publicado em: (2008)

Measuring malaria endemicity from intense to interrupted transmission
por: Hay, S, et al.
Publicado em: (2008)